AI assistant
DIRECTA PLUS PLC — Remuneration Information 2021
Jun 17, 2021
7601_def-14a_2021-06-17_05b2b610-6ebc-4b56-91b0-9b0b0c58db24.html
Remuneration Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 2967C
Directa Plus PLC
17 June 2021
17 June 2021
Directa Plus plc
("Directa Plus" or the "Company")
Grant of Options
Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that, on 15 June 2021, the Board approved the grant of performance-related options over a total of 150,000 ordinary shares of 0.25 pence each in the Company (the "Options") to Giorgio Bonfanti, Chief Financial Officer under the 2020 Employees' Share Scheme.
Subject to the satisfaction of criteria related to the Company's share price performance over the period, the Options (or a portion thereof) will vest in three equal tranches on each of the first, second and third anniversaries of the date of award. 75 per cent. of the vested Options may be exercised after the third anniversary and the remaining 25 per cent. may be exercised after the fourth anniversary. The exercise price of each Option will be 118.20 pence, which is the average closing bid price of the Company's shares on the London Stock Exchange plc for the 30 days before the date of grant.
For further information please visit http://www.directa-plus.com/ or contact:
| Directa Plus plc | +39 02 36714458 |
| Giulio Cesareo, CEO Giorgio Bonfanti, CFO |
|
| Cenkos Securities plc (Nominated Adviser and Joint Broker) | +44 131 220 6939 |
| Neil McDonald Pete Lynch |
|
| N+1 Singer (Joint Broker) | +44 20 7496 3069 |
| Rick Thompson Phil Davies |
|
| Tavistock (Financial PR and IR) | +44 20 7920 3150 |
| Simon Hudson Heather Armstrong |
About Directa Plus
Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product), textiles (based on our G+® products) and, more recently, lithium-sulphur batteries. In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+® products. All our products are hypoallergenic, non-toxic and sustainably produced.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Giorgio Bonfanti | |
| 2 | Reason for notification | ||
| a) | Position/Status | Chief Financial Officer | |
| b) | Initial notification/Amendment | Initial Notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Directa Plus plc | |
| b) | LEI | 213800X2DQST3K5ND898 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Grant of options under the Directa Plus plc 2020 Employees' Share Scheme | |
| Identification code | ISIN: GB00BSM98843 | ||
| b) | Nature of the transaction | Award of Share Options | |
| c) | Price(s) and volume(s) | Price | Volume |
| 118.2p | 150,000 | ||
| d) | Aggregated information - Aggregated volume - Price |
N/A Single Transaction | |
| e) | Date of the transaction | 15 June 2021 | |
| f) | Place of the transaction | London Stock Exchange, AIM |
-ends-
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHDKOBQQBKDAAD